Choi Kyung-Chul, Oh So-Young, Kang Hee-Bum, Lee Yoo-Hyun, Haam Seungjoo, Kim Ha-Il, Kim Kunhong, Ahn Young-Ho, Kim Kyung-Sup, Yoon Ho-Geun
Department of Biochemistry and Molecular Biology, Center for Chronic Metabolic Disease Research, Yonsei University College of Medicine, 134 Sinchon-dong, Seodaemun-gu, Seoul 120-752, South Korea.
Biochem J. 2008 Apr 1;411(1):19-26. doi: 10.1042/BJ20071393.
A central issue in mediating repression by nuclear hormone receptors is the distinct or redundant function between co-repressors N-CoR (nuclear receptor co-repressor) and SMRT (silencing mediator of retinoid and thyroid hormone receptor). To address the functional relationship between SMRT and N-CoR in TR (thyroid hormone receptor)-mediated repression, we have identified multiple TR target genes, including BCL3 (B-cell lymphoma 3-encoded protein), Spot14 (thyroid hormone-inducible hepatic protein), FAS (fatty acid synthase), and ADRB2 (beta-adrenergic receptor 2). We demonstrated that siRNA (small interfering RNA) treatment against either N-CoR or SMRT is sufficient for the de-repression of multiple TR target genes. By the combination of sequence mining and physical association as determined by ChIP (chromatin immunoprecipitation) assays, we mapped the putative TREs (thyroid hormone response elements) in BCL3, Spot14, FAS and ADRB2 genes. Our data clearly show that SMRT and N-CoR are independently recruited to various TR target genes. We also present evidence that overexpression of N-CoR can restore repression of endogenous genes after knocking down SMRT. Finally, unliganded, co-repressor-free TR is defective in repression and interacts with a co-activator, p300. Collectively, these results suggest that both SMRT and N-CoR are limited in cells and that knocking down either of them results in co-repressor-free TR and consequently de-repression of TR target genes.
核激素受体介导基因抑制的一个核心问题是共抑制因子N-CoR(核受体共抑制因子)和SMRT(视黄酸和甲状腺激素受体沉默介质)之间的独特或冗余功能。为了研究SMRT和N-CoR在甲状腺激素受体(TR)介导的基因抑制中的功能关系,我们鉴定了多个TR靶基因,包括BCL3(B细胞淋巴瘤3编码蛋白)、Spot14(甲状腺激素诱导的肝蛋白)、FAS(脂肪酸合酶)和ADRB2(β-肾上腺素能受体2)。我们证明,针对N-CoR或SMRT的小干扰RNA(siRNA)处理足以解除多个TR靶基因的抑制。通过序列挖掘和染色质免疫沉淀(ChIP)分析确定的物理相互作用相结合,我们绘制了BCL3、Spot14、FAS和ADRB2基因中假定的甲状腺激素反应元件(TRE)。我们的数据清楚地表明,SMRT和N-CoR被独立招募到各种TR靶基因。我们还提供证据表明,在敲低SMRT后,N-CoR的过表达可以恢复内源基因的抑制。最后,未结合配体、无共抑制因子的TR在抑制方面存在缺陷,并与共激活因子p300相互作用。总体而言,这些结果表明,SMRT和N-CoR在细胞中都是有限的,敲低其中任何一个都会导致无共抑制因子的TR,从而导致TR靶基因的去抑制。